What is the differential diagnosis of palpable purpura?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Differential Diagnosis of Palpable Purpura

The differential diagnosis of palpable purpura is primarily divided into small-vessel vasculitides (most commonly IgA vasculitis and cutaneous leukocytoclastic vasculitis) and conditions with microvascular occlusion, with the key distinguishing features being morphology (nonbranching versus branching), distribution (dependent versus acral/generalized), and depth of vascular involvement on biopsy.

Primary Vasculitic Causes

Small-Vessel Vasculitides

IgA vasculitis (formerly Henoch-Schönlein purpura) is the most common cause of palpable purpura in adults, accounting for approximately 59% of cases 1. This typically presents as:

  • Nonbranching (round) purpuric lesions
  • Dependent distribution (lower extremities)
  • Superficial leukocytoclastic vasculitis on biopsy
  • May have systemic features (arthralgia, GI involvement, glomerulonephritis)

Cutaneous leukocytoclastic vasculitis (CLV) represents the second most common cause at approximately 24% of cases 1. This is often:

  • Skin-limited disease without systemic involvement
  • Superficial vessel involvement only
  • May be idiopathic or secondary to drugs, infections

ANCA-associated vasculitides (AAV) including granulomatosis with polyangiitis, microscopic polyangiitis, and eosinophilic granulomatosis with polyangiitis account for approximately 3-4% of palpable purpura cases 1. Critical distinguishing features include:

  • Deep dermal and subcutaneous vessel involvement on biopsy (not just superficial) 2
  • MPO-ANCA positivity frequently associated with purpura, glomerulonephritis, and neuropathy 3
  • Systemic manifestations (renal, pulmonary, neurologic)
  • In EGPA specifically: asthma, eosinophilia, and peripheral neuropathy 4

Other Vasculitides with Immune Deposits

Cryoglobulinemic vasculitis and other immune complex-mediated vasculitides show immune deposits on immunofluorescence, distinguishing them from ANCA-associated vasculitides which are pauci-immune 3.

Rheumatologic disease-associated vasculitis (systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome) accounts for approximately 7% of cases 1.

Non-Vasculitic Causes

Microvascular Occlusion

Branching (retiform) purpura has >90% sensitivity and specificity for microvascular occlusion rather than vasculitis 2. This morphology is concerning because:

  • Associated with approximately 50% mortality 2
  • Acral branching lesions carry particularly poor prognosis
  • Causes include: disseminated intravascular coagulation, thrombotic thrombocytopenic purpura, antiphospholipid syndrome, septic emboli, cholesterol emboli, warfarin necrosis

Secondary Causes

  • Drug reactions (common precipitant) 5
  • Infections (bacterial, viral, fungal) 5
  • Malignancies (paraneoplastic, leukemia cutis) 1

Algorithmic Approach to Diagnosis

Step 1: Assess Morphology and Distribution

  • Nonbranching + dependent distribution → Likely leukocytoclastic vasculitis (IgA vasculitis or CLV)
  • Branching (retiform) pattern → Suspect microvascular occlusion; urgent evaluation needed
  • Acral or generalized distribution → Consider systemic disease or microvascular occlusion

Step 2: Obtain Skin Biopsy

  • Superficial leukocytoclastic vasculitis only → IgA vasculitis or skin-limited CLV most likely
  • Deep dermal/subcutaneous involvement → Strongly suggests systemic vasculitis (AAV, systemic disease) 2
  • Microvascular occlusion without vasculitis → Thrombotic/embolic process
  • Direct immunofluorescence: IgA deposits confirm IgA vasculitis; absence of immune deposits suggests AAV 3

Step 3: Laboratory Evaluation

  • ANCA testing (MPO-ANCA and PR3-ANCA) 3
  • Complete blood count with differential (eosinophilia in EGPA)
  • Comprehensive metabolic panel (renal function)
  • Urinalysis (hematuria, proteinuria)
  • Cryoglobulins, complement levels, hepatitis serologies
  • Blood cultures if febrile

Step 4: Assess for Systemic Involvement

  • Renal: urinalysis, creatinine
  • Pulmonary: chest imaging if respiratory symptoms
  • Neurologic: assess for mononeuritis multiplex
  • Cardiac: particularly in EGPA (troponin, ECG, echocardiogram if indicated)

Critical Pitfalls to Avoid

  1. Do not dismiss branching purpura as simple vasculitis - this pattern demands immediate evaluation for life-threatening microvascular occlusion 2

  2. Superficial biopsy may miss deep vessel involvement - ensure adequate depth when systemic vasculitis suspected 2

  3. ANCA-negative does not exclude AAV - only 30-40% of EGPA patients are ANCA-positive 3, 4

  4. Isolated P-ANCA without MPO-ANCA positivity can occur in non-vasculitic inflammatory conditions 3

  5. Approximately 7% of palpable purpura cases have non-vasculitic histopathology despite clinical appearance 1

References

5
Research

Palpable purpura: an algorithmic approach.

American family physician, 1995

Related Questions

What is the differential diagnosis of non‑palpable purpura on the lower limbs in a 14‑year‑old boy?
What are the non‑thrombocytopenic causes of purpura?
What are the possible causes of intermittent purpuric spots on the posterior thighs and how should they be evaluated and managed?
How can I differentiate purpura from bruises and determine the appropriate evaluation?
What is palpable purpura?
What are the most recent advances in audiology?
What is the carbohydrate-to-insulin ratio when 3 units of insulin cover one carb choice, expressed as 1 unit per how many grams of carbohydrate?
What are the appropriate management strategies and differential diagnoses for migraine in a 9‑year‑old child with recurrent headaches?
Is a dose of 5 units of insulin appropriate for a carbohydrate portion of 15 grams?
When the insulin‑to‑carbohydrate ratio is 1 unit per gram of carbohydrate and the correction factor is 1 unit per 50 mg/dL, what does a dose of 5 units per carbohydrate choice represent and what does the ratio 3/50 represent?
What is the likely diagnosis for a patient with an elevated thyroid‑stimulating hormone (TSH) and low‑normal triiodothyronine (T3)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.